Glimibeat Plus 1 Tablet SR
Marketer
Life Drug Pharmaceutical
Salt Composition
Glimepiride (1mg) + Metformin (850mg)
Overview Glimibeat Plus 1 Tablet SR
DiabetaComb SR, a dual-action antidiabetic medication, is indicated for adult patients with type 2 diabetes. This formulation manages blood glucose levels by combining two active ingredients. Administer DiabetaComb SR with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to kidney complications, vision loss, neuropathy, and limb damage. DiabetaComb SR complements a comprehensive diabetes management plan including dietary modifications, exercise, and weight management as directed by your healthcare provider. Lifestyle changes are integral to effective diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary foods, fruit juice) are essential preventative measures. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional possible side effects encompass altered taste perception, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections; weight gain may also occur. DiabetaComb SR is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals should consult their doctor before use. Regular blood glucose monitoring and periodic blood tests (to assess blood cell counts and liver function) are recommended.
Primary Ingredients of Glimibeat Plus 1 Tablet SR
No text was provided to rewrite.
Uses of Glimibeat Plus 1 Tablet SR
Managing type 2 diabetes
Major Benefits of Glimibeat Plus 1 Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimibeat Plus 1 Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.
Common Side effects of Glimibeat Plus 1 Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Glimibeat Plus 1 Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It is recommended to take one Glimibeat Plus sustained-release tablet with a meal.
How Glimibeat Plus 1 Tablet SR works:
Glimibeat Plus SR, a single tablet formulation, combines the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Glimibeat Plus 1 Tablet SR is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Glimibeat Plus 1 Tablet SR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescribing. Patient consultation with their doctor is advised.
Breast feedingUNSAFE
Concurrent use of Glimibeat Plus 1 Tablet SR and breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingCAUTION
Driving may be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if these conditions arise.
KidneyCAUTION
Exercise caution when prescribing Glimibeat Plus 1 Tablet SR to individuals with impaired renal function; dosage modification may be necessary. Consult a physician before administering. Glimibeat Plus 1 Tablet SR is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of renal function is recommended during treatment.
LiverCAUTION
Exercise caution when prescribing Glimibeat Plus 1 Tablet SR to individuals with hepatic impairment. Dosage modification of Glimibeat Plus 1 Tablet SR might be necessary. Physician consultation is advised. Initiation of Glimibeat Plus 1 Tablet SR therapy in patients exhibiting mild to moderate liver disease typically involves a reduced starting dose; however, its use is contraindicated in those with severe liver dysfunction.
What if you forget to take Glimibeat Plus 1 Tablet SR :
Should you forget a Glimibeat Plus 1 Tablet SR dose, take it immediately. However, if your next dose is nearly due, omit the missed dose and resume your usual dosing pattern. Never take a double dose.
Facts to Know About Glimibeat Plus 1 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |



